Seasoned finance and innovation executive brings global strategy and governance expertise to support CINV’s mission of advancing medicinal cannabis accessibility across the UK and Europe LONDON , Nov.

Showcasing progress in Clear Blue 2.0 goals of revenue growth, achieving positive Adjusted EBITDA, and cash generationToronto, Ontario--(Newsfile Corp. - November 18, 2025) - Clear Blue Technologies ...

Oruka Therapeutics, Inc. ORKA-001 Phase 1 results presented at EADV show potential for once-per-year dosing, higher efficacy ...

Third quarter 2025 net revenues were $17.6 million Emrosi™ total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call ...

Dow Jones Industrial Average, Bank of America Corp, Microsoft Corporation, Goldman Sachs Group Inc. Read 's Market Analysis on Investing.com ...